Global Adoptive Cell Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer.
LPI (LP Information)' newest research report, the “Adoptive Cell Therapy Industry Forecast” looks at past sales and reviews total world Adoptive Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Adoptive Cell Therapy sales for 2023 through 2029. With Adoptive Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adoptive Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Adoptive Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adoptive Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Adoptive Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adoptive Cell Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adoptive Cell Therapy.
The global Adoptive Cell Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Adoptive Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Adoptive Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Adoptive Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Adoptive Cell Therapy players cover Novartis, Juno, Kite, Adaptimmune, Fibrocell, Lineage Cell Therapeutics, BioTime, Vericel Corporation and Regeneus, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Adoptive Cell Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer.
LPI (LP Information)' newest research report, the “Adoptive Cell Therapy Industry Forecast” looks at past sales and reviews total world Adoptive Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Adoptive Cell Therapy sales for 2023 through 2029. With Adoptive Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adoptive Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Adoptive Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adoptive Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Adoptive Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adoptive Cell Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adoptive Cell Therapy.
The global Adoptive Cell Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Adoptive Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Adoptive Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Adoptive Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Adoptive Cell Therapy players cover Novartis, Juno, Kite, Adaptimmune, Fibrocell, Lineage Cell Therapeutics, BioTime, Vericel Corporation and Regeneus, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Adoptive Cell Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- CAR-T
- TCR-T
- NK
- TIL
- Lymphoma
- Leukemia
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Juno
- Kite
- Adaptimmune
- Fibrocell
- Lineage Cell Therapeutics
- BioTime
- Vericel Corporation
- Regeneus
- Anhui Anke Biotechnology
- Cellectis
- NantKwest
- SorrentoTherapeutics
- Bellicum
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adoptive Cell Therapy Market Size 2018-2029
2.1.2 Adoptive Cell Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Adoptive Cell Therapy Segment by Type
2.2.1 CAR-T
2.2.2 TCR-T
2.2.3 NK
2.2.4 TIL
2.3 Adoptive Cell Therapy Market Size by Type
2.3.1 Adoptive Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
2.4 Adoptive Cell Therapy Segment by Application
2.4.1 Lymphoma
2.4.2 Leukemia
2.5 Adoptive Cell Therapy Market Size by Application
2.5.1 Adoptive Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
3 ADOPTIVE CELL THERAPY MARKET SIZE BY PLAYER
3.1 Adoptive Cell Therapy Market Size Market Share by Players
3.1.1 Global Adoptive Cell Therapy Revenue by Players (2018-2023)
3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Adoptive Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADOPTIVE CELL THERAPY BY REGIONS
4.1 Adoptive Cell Therapy Market Size by Regions (2018-2023)
4.2 Americas Adoptive Cell Therapy Market Size Growth (2018-2023)
4.3 APAC Adoptive Cell Therapy Market Size Growth (2018-2023)
4.4 Europe Adoptive Cell Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Adoptive Cell Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Adoptive Cell Therapy Market Size by Country (2018-2023)
5.2 Americas Adoptive Cell Therapy Market Size by Type (2018-2023)
5.3 Americas Adoptive Cell Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adoptive Cell Therapy Market Size by Region (2018-2023)
6.2 APAC Adoptive Cell Therapy Market Size by Type (2018-2023)
6.3 APAC Adoptive Cell Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Adoptive Cell Therapy by Country (2018-2023)
7.2 Europe Adoptive Cell Therapy Market Size by Type (2018-2023)
7.3 Europe Adoptive Cell Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adoptive Cell Therapy by Region (2018-2023)
8.2 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADOPTIVE CELL THERAPY MARKET FORECAST
10.1 Global Adoptive Cell Therapy Forecast by Regions (2024-2029)
10.1.1 Global Adoptive Cell Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Adoptive Cell Therapy Forecast
10.1.3 APAC Adoptive Cell Therapy Forecast
10.1.4 Europe Adoptive Cell Therapy Forecast
10.1.5 Middle East & Africa Adoptive Cell Therapy Forecast
10.2 Americas Adoptive Cell Therapy Forecast by Country (2024-2029)
10.2.1 United States Adoptive Cell Therapy Market Forecast
10.2.2 Canada Adoptive Cell Therapy Market Forecast
10.2.3 Mexico Adoptive Cell Therapy Market Forecast
10.2.4 Brazil Adoptive Cell Therapy Market Forecast
10.3 APAC Adoptive Cell Therapy Forecast by Region (2024-2029)
10.3.1 China Adoptive Cell Therapy Market Forecast
10.3.2 Japan Adoptive Cell Therapy Market Forecast
10.3.3 Korea Adoptive Cell Therapy Market Forecast
10.3.4 Southeast Asia Adoptive Cell Therapy Market Forecast
10.3.5 India Adoptive Cell Therapy Market Forecast
10.3.6 Australia Adoptive Cell Therapy Market Forecast
10.4 Europe Adoptive Cell Therapy Forecast by Country (2024-2029)
10.4.1 Germany Adoptive Cell Therapy Market Forecast
10.4.2 France Adoptive Cell Therapy Market Forecast
10.4.3 UK Adoptive Cell Therapy Market Forecast
10.4.4 Italy Adoptive Cell Therapy Market Forecast
10.4.5 Russia Adoptive Cell Therapy Market Forecast
10.5 Middle East & Africa Adoptive Cell Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Adoptive Cell Therapy Market Forecast
10.5.2 South Africa Adoptive Cell Therapy Market Forecast
10.5.3 Israel Adoptive Cell Therapy Market Forecast
10.5.4 Turkey Adoptive Cell Therapy Market Forecast
10.5.5 GCC Countries Adoptive Cell Therapy Market Forecast
10.6 Global Adoptive Cell Therapy Forecast by Type (2024-2029)
10.7 Global Adoptive Cell Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Adoptive Cell Therapy Product Offered
11.1.3 Novartis Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Juno
11.2.1 Juno Company Information
11.2.2 Juno Adoptive Cell Therapy Product Offered
11.2.3 Juno Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Juno Main Business Overview
11.2.5 Juno Latest Developments
11.3 Kite
11.3.1 Kite Company Information
11.3.2 Kite Adoptive Cell Therapy Product Offered
11.3.3 Kite Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Kite Main Business Overview
11.3.5 Kite Latest Developments
11.4 Adaptimmune
11.4.1 Adaptimmune Company Information
11.4.2 Adaptimmune Adoptive Cell Therapy Product Offered
11.4.3 Adaptimmune Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Adaptimmune Main Business Overview
11.4.5 Adaptimmune Latest Developments
11.5 Fibrocell
11.5.1 Fibrocell Company Information
11.5.2 Fibrocell Adoptive Cell Therapy Product Offered
11.5.3 Fibrocell Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Fibrocell Main Business Overview
11.5.5 Fibrocell Latest Developments
11.6 Lineage Cell Therapeutics
11.6.1 Lineage Cell Therapeutics Company Information
11.6.2 Lineage Cell Therapeutics Adoptive Cell Therapy Product Offered
11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Lineage Cell Therapeutics Main Business Overview
11.6.5 Lineage Cell Therapeutics Latest Developments
11.7 BioTime
11.7.1 BioTime Company Information
11.7.2 BioTime Adoptive Cell Therapy Product Offered
11.7.3 BioTime Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 BioTime Main Business Overview
11.7.5 BioTime Latest Developments
11.8 Vericel Corporation
11.8.1 Vericel Corporation Company Information
11.8.2 Vericel Corporation Adoptive Cell Therapy Product Offered
11.8.3 Vericel Corporation Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Vericel Corporation Main Business Overview
11.8.5 Vericel Corporation Latest Developments
11.9 Regeneus
11.9.1 Regeneus Company Information
11.9.2 Regeneus Adoptive Cell Therapy Product Offered
11.9.3 Regeneus Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Regeneus Main Business Overview
11.9.5 Regeneus Latest Developments
11.10 Anhui Anke Biotechnology
11.10.1 Anhui Anke Biotechnology Company Information
11.10.2 Anhui Anke Biotechnology Adoptive Cell Therapy Product Offered
11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Anhui Anke Biotechnology Main Business Overview
11.10.5 Anhui Anke Biotechnology Latest Developments
11.11 Cellectis
11.11.1 Cellectis Company Information
11.11.2 Cellectis Adoptive Cell Therapy Product Offered
11.11.3 Cellectis Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Cellectis Main Business Overview
11.11.5 Cellectis Latest Developments
11.12 NantKwest
11.12.1 NantKwest Company Information
11.12.2 NantKwest Adoptive Cell Therapy Product Offered
11.12.3 NantKwest Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 NantKwest Main Business Overview
11.12.5 NantKwest Latest Developments
11.13 SorrentoTherapeutics
11.13.1 SorrentoTherapeutics Company Information
11.13.2 SorrentoTherapeutics Adoptive Cell Therapy Product Offered
11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 SorrentoTherapeutics Main Business Overview
11.13.5 SorrentoTherapeutics Latest Developments
11.14 Bellicum
11.14.1 Bellicum Company Information
11.14.2 Bellicum Adoptive Cell Therapy Product Offered
11.14.3 Bellicum Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Bellicum Main Business Overview
11.14.5 Bellicum Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adoptive Cell Therapy Market Size 2018-2029
2.1.2 Adoptive Cell Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Adoptive Cell Therapy Segment by Type
2.2.1 CAR-T
2.2.2 TCR-T
2.2.3 NK
2.2.4 TIL
2.3 Adoptive Cell Therapy Market Size by Type
2.3.1 Adoptive Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
2.4 Adoptive Cell Therapy Segment by Application
2.4.1 Lymphoma
2.4.2 Leukemia
2.5 Adoptive Cell Therapy Market Size by Application
2.5.1 Adoptive Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
3 ADOPTIVE CELL THERAPY MARKET SIZE BY PLAYER
3.1 Adoptive Cell Therapy Market Size Market Share by Players
3.1.1 Global Adoptive Cell Therapy Revenue by Players (2018-2023)
3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Adoptive Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADOPTIVE CELL THERAPY BY REGIONS
4.1 Adoptive Cell Therapy Market Size by Regions (2018-2023)
4.2 Americas Adoptive Cell Therapy Market Size Growth (2018-2023)
4.3 APAC Adoptive Cell Therapy Market Size Growth (2018-2023)
4.4 Europe Adoptive Cell Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Adoptive Cell Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Adoptive Cell Therapy Market Size by Country (2018-2023)
5.2 Americas Adoptive Cell Therapy Market Size by Type (2018-2023)
5.3 Americas Adoptive Cell Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adoptive Cell Therapy Market Size by Region (2018-2023)
6.2 APAC Adoptive Cell Therapy Market Size by Type (2018-2023)
6.3 APAC Adoptive Cell Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Adoptive Cell Therapy by Country (2018-2023)
7.2 Europe Adoptive Cell Therapy Market Size by Type (2018-2023)
7.3 Europe Adoptive Cell Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adoptive Cell Therapy by Region (2018-2023)
8.2 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADOPTIVE CELL THERAPY MARKET FORECAST
10.1 Global Adoptive Cell Therapy Forecast by Regions (2024-2029)
10.1.1 Global Adoptive Cell Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Adoptive Cell Therapy Forecast
10.1.3 APAC Adoptive Cell Therapy Forecast
10.1.4 Europe Adoptive Cell Therapy Forecast
10.1.5 Middle East & Africa Adoptive Cell Therapy Forecast
10.2 Americas Adoptive Cell Therapy Forecast by Country (2024-2029)
10.2.1 United States Adoptive Cell Therapy Market Forecast
10.2.2 Canada Adoptive Cell Therapy Market Forecast
10.2.3 Mexico Adoptive Cell Therapy Market Forecast
10.2.4 Brazil Adoptive Cell Therapy Market Forecast
10.3 APAC Adoptive Cell Therapy Forecast by Region (2024-2029)
10.3.1 China Adoptive Cell Therapy Market Forecast
10.3.2 Japan Adoptive Cell Therapy Market Forecast
10.3.3 Korea Adoptive Cell Therapy Market Forecast
10.3.4 Southeast Asia Adoptive Cell Therapy Market Forecast
10.3.5 India Adoptive Cell Therapy Market Forecast
10.3.6 Australia Adoptive Cell Therapy Market Forecast
10.4 Europe Adoptive Cell Therapy Forecast by Country (2024-2029)
10.4.1 Germany Adoptive Cell Therapy Market Forecast
10.4.2 France Adoptive Cell Therapy Market Forecast
10.4.3 UK Adoptive Cell Therapy Market Forecast
10.4.4 Italy Adoptive Cell Therapy Market Forecast
10.4.5 Russia Adoptive Cell Therapy Market Forecast
10.5 Middle East & Africa Adoptive Cell Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Adoptive Cell Therapy Market Forecast
10.5.2 South Africa Adoptive Cell Therapy Market Forecast
10.5.3 Israel Adoptive Cell Therapy Market Forecast
10.5.4 Turkey Adoptive Cell Therapy Market Forecast
10.5.5 GCC Countries Adoptive Cell Therapy Market Forecast
10.6 Global Adoptive Cell Therapy Forecast by Type (2024-2029)
10.7 Global Adoptive Cell Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Adoptive Cell Therapy Product Offered
11.1.3 Novartis Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Juno
11.2.1 Juno Company Information
11.2.2 Juno Adoptive Cell Therapy Product Offered
11.2.3 Juno Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Juno Main Business Overview
11.2.5 Juno Latest Developments
11.3 Kite
11.3.1 Kite Company Information
11.3.2 Kite Adoptive Cell Therapy Product Offered
11.3.3 Kite Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Kite Main Business Overview
11.3.5 Kite Latest Developments
11.4 Adaptimmune
11.4.1 Adaptimmune Company Information
11.4.2 Adaptimmune Adoptive Cell Therapy Product Offered
11.4.3 Adaptimmune Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Adaptimmune Main Business Overview
11.4.5 Adaptimmune Latest Developments
11.5 Fibrocell
11.5.1 Fibrocell Company Information
11.5.2 Fibrocell Adoptive Cell Therapy Product Offered
11.5.3 Fibrocell Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Fibrocell Main Business Overview
11.5.5 Fibrocell Latest Developments
11.6 Lineage Cell Therapeutics
11.6.1 Lineage Cell Therapeutics Company Information
11.6.2 Lineage Cell Therapeutics Adoptive Cell Therapy Product Offered
11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Lineage Cell Therapeutics Main Business Overview
11.6.5 Lineage Cell Therapeutics Latest Developments
11.7 BioTime
11.7.1 BioTime Company Information
11.7.2 BioTime Adoptive Cell Therapy Product Offered
11.7.3 BioTime Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 BioTime Main Business Overview
11.7.5 BioTime Latest Developments
11.8 Vericel Corporation
11.8.1 Vericel Corporation Company Information
11.8.2 Vericel Corporation Adoptive Cell Therapy Product Offered
11.8.3 Vericel Corporation Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Vericel Corporation Main Business Overview
11.8.5 Vericel Corporation Latest Developments
11.9 Regeneus
11.9.1 Regeneus Company Information
11.9.2 Regeneus Adoptive Cell Therapy Product Offered
11.9.3 Regeneus Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Regeneus Main Business Overview
11.9.5 Regeneus Latest Developments
11.10 Anhui Anke Biotechnology
11.10.1 Anhui Anke Biotechnology Company Information
11.10.2 Anhui Anke Biotechnology Adoptive Cell Therapy Product Offered
11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Anhui Anke Biotechnology Main Business Overview
11.10.5 Anhui Anke Biotechnology Latest Developments
11.11 Cellectis
11.11.1 Cellectis Company Information
11.11.2 Cellectis Adoptive Cell Therapy Product Offered
11.11.3 Cellectis Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Cellectis Main Business Overview
11.11.5 Cellectis Latest Developments
11.12 NantKwest
11.12.1 NantKwest Company Information
11.12.2 NantKwest Adoptive Cell Therapy Product Offered
11.12.3 NantKwest Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 NantKwest Main Business Overview
11.12.5 NantKwest Latest Developments
11.13 SorrentoTherapeutics
11.13.1 SorrentoTherapeutics Company Information
11.13.2 SorrentoTherapeutics Adoptive Cell Therapy Product Offered
11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 SorrentoTherapeutics Main Business Overview
11.13.5 SorrentoTherapeutics Latest Developments
11.14 Bellicum
11.14.1 Bellicum Company Information
11.14.2 Bellicum Adoptive Cell Therapy Product Offered
11.14.3 Bellicum Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Bellicum Main Business Overview
11.14.5 Bellicum Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Adoptive Cell Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of CAR-T
Table 3. Major Players of TCR-T
Table 4. Major Players of NK
Table 5. Major Players of TIL
Table 6. Adoptive Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Adoptive Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Table 9. Adoptive Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Adoptive Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Table 12. Global Adoptive Cell Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Adoptive Cell Therapy Revenue Market Share by Player (2018-2023)
Table 14. Adoptive Cell Therapy Key Players Head office and Products Offered
Table 15. Adoptive Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Adoptive Cell Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Adoptive Cell Therapy Market Size Market Share by Regions (2018-2023)
Table 20. Global Adoptive Cell Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Adoptive Cell Therapy Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Adoptive Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Adoptive Cell Therapy Market Size Market Share by Country (2018-2023)
Table 24. Americas Adoptive Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Table 26. Americas Adoptive Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Table 28. APAC Adoptive Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Adoptive Cell Therapy Market Size Market Share by Region (2018-2023)
Table 30. APAC Adoptive Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Table 32. APAC Adoptive Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Table 34. Europe Adoptive Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Adoptive Cell Therapy Market Size Market Share by Country (2018-2023)
Table 36. Europe Adoptive Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Table 38. Europe Adoptive Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Adoptive Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Adoptive Cell Therapy Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Adoptive Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Adoptive Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Adoptive Cell Therapy
Table 47. Key Market Challenges & Risks of Adoptive Cell Therapy
Table 48. Key Industry Trends of Adoptive Cell Therapy
Table 49. Global Adoptive Cell Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Adoptive Cell Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Adoptive Cell Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Adoptive Cell Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Novartis Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 54. Novartis Adoptive Cell Therapy Product Offered
Table 55. Novartis Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Novartis Main Business
Table 57. Novartis Latest Developments
Table 58. Juno Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 59. Juno Adoptive Cell Therapy Product Offered
Table 60. Juno Main Business
Table 61. Juno Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Juno Latest Developments
Table 63. Kite Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 64. Kite Adoptive Cell Therapy Product Offered
Table 65. Kite Main Business
Table 66. Kite Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Kite Latest Developments
Table 68. Adaptimmune Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 69. Adaptimmune Adoptive Cell Therapy Product Offered
Table 70. Adaptimmune Main Business
Table 71. Adaptimmune Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Adaptimmune Latest Developments
Table 73. Fibrocell Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 74. Fibrocell Adoptive Cell Therapy Product Offered
Table 75. Fibrocell Main Business
Table 76. Fibrocell Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Fibrocell Latest Developments
Table 78. Lineage Cell Therapeutics Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 79. Lineage Cell Therapeutics Adoptive Cell Therapy Product Offered
Table 80. Lineage Cell Therapeutics Main Business
Table 81. Lineage Cell Therapeutics Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Lineage Cell Therapeutics Latest Developments
Table 83. BioTime Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 84. BioTime Adoptive Cell Therapy Product Offered
Table 85. BioTime Main Business
Table 86. BioTime Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. BioTime Latest Developments
Table 88. Vericel Corporation Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 89. Vericel Corporation Adoptive Cell Therapy Product Offered
Table 90. Vericel Corporation Main Business
Table 91. Vericel Corporation Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Vericel Corporation Latest Developments
Table 93. Regeneus Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 94. Regeneus Adoptive Cell Therapy Product Offered
Table 95. Regeneus Main Business
Table 96. Regeneus Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Regeneus Latest Developments
Table 98. Anhui Anke Biotechnology Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 99. Anhui Anke Biotechnology Adoptive Cell Therapy Product Offered
Table 100. Anhui Anke Biotechnology Main Business
Table 101. Anhui Anke Biotechnology Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Anhui Anke Biotechnology Latest Developments
Table 103. Cellectis Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 104. Cellectis Adoptive Cell Therapy Product Offered
Table 105. Cellectis Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Cellectis Main Business
Table 107. Cellectis Latest Developments
Table 108. NantKwest Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 109. NantKwest Adoptive Cell Therapy Product Offered
Table 110. NantKwest Main Business
Table 111. NantKwest Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. NantKwest Latest Developments
Table 113. SorrentoTherapeutics Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 114. SorrentoTherapeutics Adoptive Cell Therapy Product Offered
Table 115. SorrentoTherapeutics Main Business
Table 116. SorrentoTherapeutics Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. SorrentoTherapeutics Latest Developments
Table 118. Bellicum Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 119. Bellicum Adoptive Cell Therapy Product Offered
Table 120. Bellicum Main Business
Table 121. Bellicum Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Bellicum Latest Developments
Table 1. Adoptive Cell Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of CAR-T
Table 3. Major Players of TCR-T
Table 4. Major Players of NK
Table 5. Major Players of TIL
Table 6. Adoptive Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Adoptive Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Table 9. Adoptive Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Adoptive Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Table 12. Global Adoptive Cell Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Adoptive Cell Therapy Revenue Market Share by Player (2018-2023)
Table 14. Adoptive Cell Therapy Key Players Head office and Products Offered
Table 15. Adoptive Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Adoptive Cell Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Adoptive Cell Therapy Market Size Market Share by Regions (2018-2023)
Table 20. Global Adoptive Cell Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Adoptive Cell Therapy Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Adoptive Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Adoptive Cell Therapy Market Size Market Share by Country (2018-2023)
Table 24. Americas Adoptive Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Table 26. Americas Adoptive Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Table 28. APAC Adoptive Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Adoptive Cell Therapy Market Size Market Share by Region (2018-2023)
Table 30. APAC Adoptive Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Table 32. APAC Adoptive Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Table 34. Europe Adoptive Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Adoptive Cell Therapy Market Size Market Share by Country (2018-2023)
Table 36. Europe Adoptive Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Table 38. Europe Adoptive Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Adoptive Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Adoptive Cell Therapy Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Adoptive Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Adoptive Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Adoptive Cell Therapy
Table 47. Key Market Challenges & Risks of Adoptive Cell Therapy
Table 48. Key Industry Trends of Adoptive Cell Therapy
Table 49. Global Adoptive Cell Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Adoptive Cell Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Adoptive Cell Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Adoptive Cell Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Novartis Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 54. Novartis Adoptive Cell Therapy Product Offered
Table 55. Novartis Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Novartis Main Business
Table 57. Novartis Latest Developments
Table 58. Juno Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 59. Juno Adoptive Cell Therapy Product Offered
Table 60. Juno Main Business
Table 61. Juno Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Juno Latest Developments
Table 63. Kite Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 64. Kite Adoptive Cell Therapy Product Offered
Table 65. Kite Main Business
Table 66. Kite Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Kite Latest Developments
Table 68. Adaptimmune Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 69. Adaptimmune Adoptive Cell Therapy Product Offered
Table 70. Adaptimmune Main Business
Table 71. Adaptimmune Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Adaptimmune Latest Developments
Table 73. Fibrocell Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 74. Fibrocell Adoptive Cell Therapy Product Offered
Table 75. Fibrocell Main Business
Table 76. Fibrocell Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Fibrocell Latest Developments
Table 78. Lineage Cell Therapeutics Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 79. Lineage Cell Therapeutics Adoptive Cell Therapy Product Offered
Table 80. Lineage Cell Therapeutics Main Business
Table 81. Lineage Cell Therapeutics Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Lineage Cell Therapeutics Latest Developments
Table 83. BioTime Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 84. BioTime Adoptive Cell Therapy Product Offered
Table 85. BioTime Main Business
Table 86. BioTime Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. BioTime Latest Developments
Table 88. Vericel Corporation Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 89. Vericel Corporation Adoptive Cell Therapy Product Offered
Table 90. Vericel Corporation Main Business
Table 91. Vericel Corporation Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Vericel Corporation Latest Developments
Table 93. Regeneus Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 94. Regeneus Adoptive Cell Therapy Product Offered
Table 95. Regeneus Main Business
Table 96. Regeneus Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Regeneus Latest Developments
Table 98. Anhui Anke Biotechnology Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 99. Anhui Anke Biotechnology Adoptive Cell Therapy Product Offered
Table 100. Anhui Anke Biotechnology Main Business
Table 101. Anhui Anke Biotechnology Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Anhui Anke Biotechnology Latest Developments
Table 103. Cellectis Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 104. Cellectis Adoptive Cell Therapy Product Offered
Table 105. Cellectis Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Cellectis Main Business
Table 107. Cellectis Latest Developments
Table 108. NantKwest Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 109. NantKwest Adoptive Cell Therapy Product Offered
Table 110. NantKwest Main Business
Table 111. NantKwest Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. NantKwest Latest Developments
Table 113. SorrentoTherapeutics Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 114. SorrentoTherapeutics Adoptive Cell Therapy Product Offered
Table 115. SorrentoTherapeutics Main Business
Table 116. SorrentoTherapeutics Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. SorrentoTherapeutics Latest Developments
Table 118. Bellicum Details, Company Type, Adoptive Cell Therapy Area Served and Its Competitors
Table 119. Bellicum Adoptive Cell Therapy Product Offered
Table 120. Bellicum Main Business
Table 121. Bellicum Adoptive Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Bellicum Latest Developments
LIST OF FIGURES
Figure 1. Adoptive Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adoptive Cell Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Adoptive Cell Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Adoptive Cell Therapy Sales Market Share by Country/Region (2022)
Figure 8. Adoptive Cell Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Adoptive Cell Therapy Market Size Market Share by Type in 2022
Figure 10. Adoptive Cell Therapy in Lymphoma
Figure 11. Global Adoptive Cell Therapy Market: Lymphoma (2018-2023) & ($ Millions)
Figure 12. Adoptive Cell Therapy in Leukemia
Figure 13. Global Adoptive Cell Therapy Market: Leukemia (2018-2023) & ($ Millions)
Figure 14. Global Adoptive Cell Therapy Market Size Market Share by Application in 2022
Figure 15. Global Adoptive Cell Therapy Revenue Market Share by Player in 2022
Figure 16. Global Adoptive Cell Therapy Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Adoptive Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 18. APAC Adoptive Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 19. Europe Adoptive Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Adoptive Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Americas Adoptive Cell Therapy Value Market Share by Country in 2022
Figure 22. United States Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Adoptive Cell Therapy Market Size Market Share by Region in 2022
Figure 27. APAC Adoptive Cell Therapy Market Size Market Share by Type in 2022
Figure 28. APAC Adoptive Cell Therapy Market Size Market Share by Application in 2022
Figure 29. China Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Adoptive Cell Therapy Market Size Market Share by Country in 2022
Figure 36. Europe Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 37. Europe Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 38. Germany Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Adoptive Cell Therapy Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 52. APAC Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 53. Europe Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 55. United States Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Canada Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 59. China Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Japan Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Korea Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 63. India Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Australia Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Germany Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 66. France Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 67. UK Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Italy Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Russia Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Spain Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Israel Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Global Adoptive Cell Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Adoptive Cell Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Adoptive Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adoptive Cell Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Adoptive Cell Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Adoptive Cell Therapy Sales Market Share by Country/Region (2022)
Figure 8. Adoptive Cell Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Adoptive Cell Therapy Market Size Market Share by Type in 2022
Figure 10. Adoptive Cell Therapy in Lymphoma
Figure 11. Global Adoptive Cell Therapy Market: Lymphoma (2018-2023) & ($ Millions)
Figure 12. Adoptive Cell Therapy in Leukemia
Figure 13. Global Adoptive Cell Therapy Market: Leukemia (2018-2023) & ($ Millions)
Figure 14. Global Adoptive Cell Therapy Market Size Market Share by Application in 2022
Figure 15. Global Adoptive Cell Therapy Revenue Market Share by Player in 2022
Figure 16. Global Adoptive Cell Therapy Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Adoptive Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 18. APAC Adoptive Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 19. Europe Adoptive Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Adoptive Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Americas Adoptive Cell Therapy Value Market Share by Country in 2022
Figure 22. United States Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Adoptive Cell Therapy Market Size Market Share by Region in 2022
Figure 27. APAC Adoptive Cell Therapy Market Size Market Share by Type in 2022
Figure 28. APAC Adoptive Cell Therapy Market Size Market Share by Application in 2022
Figure 29. China Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Adoptive Cell Therapy Market Size Market Share by Country in 2022
Figure 36. Europe Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 37. Europe Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 38. Germany Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Adoptive Cell Therapy Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Adoptive Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Adoptive Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Adoptive Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 52. APAC Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 53. Europe Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 55. United States Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Canada Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 59. China Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Japan Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Korea Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 63. India Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Australia Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Germany Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 66. France Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 67. UK Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Italy Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Russia Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Spain Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Israel Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Adoptive Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Global Adoptive Cell Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Adoptive Cell Therapy Market Size Market Share Forecast by Application (2024-2029)
